XML 8 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 21,126 $ 33,218
Marketable securities 136,400 150,236
Prepaid expenses and other current assets 7,959 11,850
Total current assets 165,485 195,304
Property and equipment, net 855 881
Operating lease right-of-use assets 2,647 2,838
Restricted cash 606 606
Other assets 582 596
Total assets 170,175 200,225
Current liabilities:    
Accounts payable 2,274 2,424
Accrued expenses 18,764 20,872
Operating lease liabilities, current 1,096 1,060
Total current liabilities 22,134 24,356
Operating lease liabilities 3,770 4,057
Total liabilities 25,904 28,413
Commitments and contingencies (See Note 8)
Stockholders’ equity:    
Preferred stock; $0.001 par value per share; 5,000,000 shares authorized as of March 31, 2025 and December 31, 2024; no shares issued and outstanding as of March 31, 2025 and December 31, 2024
Common stock, $0.001 par value per share; 115,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 64,027,892 and 63,815,065 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively 64 64
Additional paid-in capital 442,592 440,758
Accumulated deficit (298,439) (269,158)
Accumulated other comprehensive gain 54 148
Total stockholders’ equity 144,271 171,812
Total liabilities and stockholders’ equity $ 170,175 $ 200,225